BBS-Bioactive Bone Substitutes Oyj Balance Sheet Health
Financial Health criteria checks 3/6
BBS-Bioactive Bone Substitutes Oyj has a total shareholder equity of €3.8M and total debt of €5.6M, which brings its debt-to-equity ratio to 147.1%. Its total assets and total liabilities are €9.4M and €5.6M respectively.
Key information
147.1%
Debt to equity ratio
€5.58m
Debt
| Interest coverage ratio | n/a |
| Cash | €850.00k |
| Equity | €3.79m |
| Total liabilities | €5.58m |
| Total assets | €9.37m |
Recent financial health updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16
BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Recent updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Financial Position Analysis
Short Term Liabilities: BONEH's short term assets (€886.0K) do not cover its short term liabilities (€2.3M).
Long Term Liabilities: BONEH's short term assets (€886.0K) do not cover its long term liabilities (€3.3M).
Debt to Equity History and Analysis
Debt Level: BONEH's net debt to equity ratio (124.7%) is considered high.
Reducing Debt: BONEH's debt to equity ratio has reduced from 177.9% to 147.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BONEH has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BONEH is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.